GTCR completed the $200m minority investment in Solmetex.

GTCR, a private equity firm, completed the $200m minority investment in Solmetex, a provider of dental products, systems, and consumables. "We are excited to support Solmetex's next phase of growth. Solmetex is a high-quality business that is uniquely situated in the dental supply chain, and we look forward to leveraging our team's investment expertise across the U.S. healthcare ecosystem to build upon its strong foundation," Luke Marker, GTCR Managing Director.